Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleA phase II study of the dual mTOR inhibitor MLN0128 in patients with metastatic castration resistant prostate cancer.AuthorsGraham, Laura; Banda, Kalyan; Torres, Alba; Carver, Brett S.; Chen, Yu; Pisano, Katie; Shelkey, Greg; Curley, Tracy; Scher, Howard I.; Lotan, Tamara L.; Hsieh, Andrew C.; Rathkopf, Dana E.PublicationInvestigational New Drugs, 2018, Vol 36, Issue 3, p458ISSN0167-6997Publication typeArticleDOI10.1007/s10637-018-0578-9